Michal Lach, through the company he owns company eCapital, increasedhe increased its capital commitment to NanoGroup SA. The investor subscribed to another pool of M2 shares for a total of 809,524 shares.
The acquisition of another pool of shares is the result of the fulfillment by the NanoSanguis S.A., one of the companies NanoGroup, a milestone in the form of a successful kidney autotransplantation experiment.
This was one of the conditions listed in the investment agreement between the eCapital Sp.
Ltd. owned by Michal Lach, and the group.
The experiment confirmed the effectiveness of the innovative NanOX system.
NanOX is a comprehensive and proprietary system of devices and innovative fluids for extracorporeal storage, as well as organ regeneration for transplantation.
It consists of NanOX 4K perfusion fluid, the NanOX Recovery Box universal perfusion device, which monitors vital organ functions, and a proprietary organ perfusion protocol.
Thank you for your trust and support in the further development of NanoGroup’s technology.
Read more: BANKIER.PL, PARKIET(ALSO HERE), TRADING VIEW, COMPARIC, FXMAG, GPW, PULS BIZNESU, BIZNES INTERIA, BIZNES PAP, INFOSTREFA,STOCKWATCH, MONEY.PL.